Peripheral nerve tumors: Management strategies and molecular insights

Journal of Neuro-Oncology

Volumn 69, Issue 1-3, 2004, Pages 335-349

  Bhattacharyya, Asis Kumar ^a   Perrin, Richard ^a   Guha, Abhijit ^a,b  

^a TORONTO WESTERN HOSPITAL   (Canada)

^b HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

Author keywords

Experimental therapies; Malignant peripheral nerve sheath tumor (MPNST); Neurofibromatosis (NF); Peripheral nerve tumor (PNT); Signaling

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; MERLIN; NEUROFIBROMIN; PROTEIN P53; TUMOR SUPPRESSOR PROTEIN;

ALGORITHM; ANAMNESIS; ARTICLE; BRAIN METASTASIS; BRAIN RADIOGRAPHY; CANCER CLASSIFICATION; CANCER INCIDENCE; CANCER RADIOTHERAPY; CLINICAL FEATURE; CLINICAL PROTOCOL; DESMOID TUMOR; DISEASE ACTIVITY; FOLLOW UP; GANGLION CYST; GENETIC ANALYSIS; HUMAN; LIPOMA; MEDICAL DECISION MAKING; MEDICAL EXPERT; NEURILEMOMA; NEURITIS; NEUROFIBROMA; NEUROFIBROMATOSIS; PANCOAST TUMOR; PATIENT CARE; PERIPHERAL NERVE TUMOR; PEROPERATIVE CARE; PHYSICAL EXAMINATION; POSTOPERATIVE CARE; PRACTICE GUIDELINE; RARE DISEASE; TUMOR LOCALIZATION;

HUMANS; PERIPHERAL NERVOUS SYSTEM NEOPLASMS;

EID: 19444367448     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:NEON.0000041891.39474.cb     Document Type: Article

References (57)

1. Ferner R, Gutmann D, Coffin C, Grimer R, Guha A, Judson I, Sandison A, Smith M, Viskochil D: International Consensus statement on Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis 1. Cancer Res 62: 1573-1577, 2002
2. Evans DG, Huson SM, Donani D, Neary W, Blair V, Teare D, Newton V, Strachan T, Ramsden R, Harris R: A genetic study of type 2 neurofibromatosis in the United Kingdom. I. Prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severity. J Med Genet 29(12): 841-846, 1992
3. Antiheimo J, Sankila R, Carpen O, Pukkala M, Sainio M, Jaaskelainen J: Population-based analysis of sporadic and type 2 neurofibromatosis-associated meningiomas and schwannomas. Neurology 54(1): 71-76, 2000
4. Gutman DH, Aylsworth A, Carey JC, Korf B, Marks J, Pyeritz RE et al.: The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA 278(1): 51-57, 1997 (Review)
5. Evans DG, Huson SM, Donnai D, Neary W, Blair V, Newton V, Harris R: A clinical study of type 2 neurofibromatosis. Q J Med 84(304): 603-618, 1992
6. Martuza RL, Eldridge R: Neurofibromatosis 2 (bilateral acoustic neurofibromatosis). N Eng J Med 318(11): 684-688, 1988
7. Halliday AL, Sobel RA, Martuza RL: Benign spinal nerve sheath tumors: their occurrence sporadically and in neurofibromatosis types 1 and 2. J Neurosurg 74(2) :248-253, 1991
8. Kluwe L, Friedrich RE, Hagel C, Lindenau M, Mautner VF. Mutations and allelic loss of the NF2 gene in neurofibromatosis 2-associated skin tumors. J Invest Dermatol 114(5): 1017-1021, 2000
9. Ishida T, Kuroda M, Motoi T, Oka T, Imamura T, Machinami R: Phenotypic diversity of neurofibromatosis 2: association with plexiform schwannoma. Histopathology 32(3): 264-270, 1998
10. Trofatter JA, MacColli MM, Rutter MJR, Duyao MP, Parry DM, Eldridge R, Kley N, Menon AG, Pulaski K: A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 19; 75(4): 826, 1993
11. Rouleau GA, Merel P, Lutchman M, Sanson M, Zuchman J, Marineau C, Hoang-Xuan K, Demczuk S, Desmaze C, Plougastel B: Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature 363(6429): 515-521, 1993
12. Gutmann DH, Giordano MJ, Fishback AS, Guha A: Loss of merlin expression in sporadic meningiomas, ependymomas and schwannomas. Neurology 49(1): 267-270, 1997
13. Antiheimo J, Sallinen SL, Sallinen P, Haapasalo H, Helin H, Horelli-Kuitunen N, Wessman M, Sainio M, Jaaskelainen J, Carpen O: Genetic aberrations in sporadic and neurofibromatosis 2 (NF2)-associated schwannomas studied by comparative genomic hybridization (CGH). Acta Neurochir (Wien) 142(10): 1099-1104, 2000 (discussion 1104-1105)
14. Purcell SM, Dixon SL: Schwannomatosis. An unusual variant of neurofibromatosis or a distinct clinical entity? Arch Dermatol 125(3): 390-393, 1989
15. Jacoby LB, Jones D, Davis K, Kronn D, Short MP, Gusella J, MacCollin M: Molecular analysis of the NF2 tumor-suppressor gene in schwannomatosis. Am J Hum Genet 61(6): 1293-1302, 1997
16. Zeller ME, Rembeck B, Oden A, Samuelsson M, Angervall L: Malignant and benign tumors in patients with neuofibromatosis type 1 in a defied Swedish population. Cancer 79(11): 2125-2131, 1997
17. Sorensen SA, Mulvihill J, Nielsen A: A long-term follow up of von Recklinghausen neurofibromatosis: survival and malignant neoplasm. N Eng J Med 314(16): 1010-1015, 1986
18. Angelov L, Guha A: Periperal neve tumors. In: Bernstein M, Berger MS (eds) Neurooncology: The Essentials, New York, Thieme Medical Publishers: 2000, pp 434-444
19. Huson SM, Compston DA, Clark P, Harper PS: A genetic study of von Recklinghausen neurofibromatosis in south east Wales. I. Prevalence, fitness, mutation rate, and effect of parental transmission on severity. J Med Genet 26(11): 704-711, 1989
20. Riccardi V: Neurofibromatosis: Phenotype, Natural history and Pathogenesis. Baltimore: John Hopkins Univ. Press, 1992
21. Fountain JW, Wallace MR, Brereton AM, O'Connell P, White RL, Rich DC, Ledbetter DH, Leach RJ, Fournier RE, Menon AG: Physical mapping of the von Recklinghausen neurofibromatosis region on chromosome 17. Am J Hum Genet 44(1): 58-67, 1989
22. Li Y, O'Connell P, Breidenbach HH, Cawthon R, Stevens J, Xu G, Neil S, Robertson M, White R, Viskochil D: Genomic organization of the neurofibromatosis 1 gene (NF1). Genomics 25(1): 9-18, 1995
23. Lakkis MM, Tennekoon GI: Neurofibromatosis type 1. I. General overview. J Neurosci Res 62(6): 755-763, 2000 (Review)
24. Nishi T, Lee PS, Oka K, Levin VA, Tanase A, Morino Y, Saya H: Differential expression of two types of the neurofibromatosis type 1 (NF1) gene transcripts related to neuronal differentiation. Oncogene 6(9): 1555-1559, 1991
25. Gutmann DH, Geist RT, Rose K, Wright DE: Expression of two new protein isoforms of the neurofibromatosis type 1 gene product, neurofibromin, in muscle tissues. Dev Dyn 202(3): 302-311, 1995
26. Guha A, Lau N, Huvar I, Gutmann D, Provias J, Pawson T, Boss G: Ras-GTP levels are elevated in human NF1 peripheral nerve tumors. Oncogene 12(3): 507-513, 1996
27. Menon AG, Anderson KM, Riccardi VM, Chung RY, Whaley JM, Yandell DW, Farmer GE, Freiman RN, Lee JK, Li FP: Chromosome 17p deletions and p53 gene mutations associated with the formation of malignant neurofibrosarcomas in von Recklinghausen neurofibromatosis. Proc Natl Acad Sci USA 87(14): 5435-5439, 1990
28. Upadhyaya M, Shen M, Cherryson A, Farnham J, Maynard J, Huson SM, Harper PS: Analysis of mutations at the neurofibromatosis 1 (NF1) locus. Hum Mol Genet 1(9): 735-740, 1992
29. Hofman KJ, Boehm CED: Familial neurofibromatosis type 1: clinical experience with DNA testing. J Pediatr 120(3): 394-398, 1992
30. North K: Neurofibromatosis type 1. Am J Med Genet 97(2): 119-127, 2000
31. Kalff V, Shapiro B, Lloyd R, Sisson JC, Holland K, Nakajo M, Beierwaltes WH: The spectrum of pheochromocytoma in hypertensive patients with neurofibromatosis. Arch Intern Med 142(12): 2092-2098, 1982
32. Salyer WR, Salyer DC: The vascular lesions of neurofibromatosis. Angiology 25(8): 510-519, 1974
33. Zvulunov A, Barak Y, Metzker A: Juvenile xanthogranuloma, neurofibromatosis, and juvenile chronic myelogenous leukemia. World statistical analysis. Arch Dermatol.131(8): 904 908, 1995 (Review)
34. Griffiths DF, Williams GT, Williams ED: Duodenal carcinoid tumours, phaeochromocytoma and neurofibromatosis: islet cell tumour, phaeochromocytoma, and the von Hippel-Lindau complex: two distinctive neuroendocrine syndromes. Q J Med 64(245): 769-782, 1987
35. Crawford AH: Neurofibromatosis in children. Acta Orthop Scand Suppl 218: 1-60, 1986
36. Gholkar A, Stack JP, Isherwood I: Plexiform trigeminal neurofibroma. Clin Radiol 39(3): 313-315, 1988
37. Korf BR: Plexiform neurofibromas. Am J Med Genet 89(1): 31-37, 1999
38. Krueger W, Weisberger E, Bllantyne AJ, Goepfert H: Plexiform neurofibroma of the head and neck. Am J Surg 138(4): 517-520, 1979
39. Riccardi VM: A controlled multiphase trial of kitotifen to minimize neurofibroma-associated pain and itching. Arch Dermatol 129(5): 577-581, 1993
40. Gupta A, Cohen B, Ruggierri P Packer RJ, Phillips PC: A phase 1 study of Thalidomide for the treatment of plexiform neurofibroma in neurofibromatosis 1. Neurology 60(1): 130-132, 2003
41. Tinschert S, Naumann I, Stegmann E, Buske A, Kaufmann D, Thiel G, Jenne DE: Segmental neurofibromatosis is caused by somatic mutation of the neurofibromatosis type 1 (NF1) gene. Eur J Hum Genet 8(6): 455-459, 2000
42. Tsangn WY, Chan JK, Chow LT, Tse CC: Perineurioma: an uncommon soft tissue neoplasm distinct from localized hypertrophic neuropathy and neurofibroma. Am J Surg Pathol 16(8): 756-763, 1992 (Review)
43. Ohno T, Park P, Akai M, Kamura S, Murase K, Kimura H, Kadoya H, Manabe S, Nagao K, Sugano I: Ultrastructural study of a perineurioma. Ultrastruct Pathol 12(5): 495-504, 1988 (Review)
44. Fletcher CD: Solitary circumscribed neuroma of the skin (so-called palisaded, encapsulated neuroma). A clinicopathologic and immunohistochemical study. Am J Surg Pathol 13(7): 574-580, 1989
45. Megahed M: Palisaded encapsulated neuroma (solitary circumscribed neuroma). A clinicopathologic and immunohistochemical study. Am J Dermatopathol 16(2): 120-125, 1994
46. Busam KJ, Mentzel T, Colpaert C, Branhill RL, Fletcher CD: Atypical or worrisome features in cellular neurothekeoma: a study of 10 cases. Am J Surg Pathol 22(9): 1067-1072, 1998
47. Plukker JT, van Oort I, Vermey A, Molenaar I, Hoekstra HJ, Panders AK, Dolsma WV, Keeps HS: Aggressive fibromatosis (non-familial desmoid tumour): therapeutic problems and the role of adjuvant radiotherapy. Br J Surg 82(4): 510-514, 1995
48. Hoes A, Lewis JJ, Urist MJ, Shaba AR, Hawkins WG, Shah JP, Brennan MF: Desmoid tumors of the head and neck-a clinical study of a rare entity. Head Neck 22(8): 814-821, 2000
49. Perez-Lopez C, Gutierrez M, Isla A: Inflammatory pseudotumor of the median nerve. Case report and review of the literature. J Neurosurg 95(1): 124-128, 2001 (Review)
50. Beer T, Carr NJ, Weller RO: Inflammatory pseudotumor of peripheral nerve. Am J Surg Pathol 22(8): 1035-1036, 1998
51. Angelov A, Davis A, O'Sullivan B, Bell R, Guha A: Neurogenic sarcoma: experience at the University of Toronto. Nurosurgery 43(1): 56-64, 1998
52. Misdraji J, Ino Y, Louis DN, Rosenberg AE, Chiocca EA, Harris NL: Primary lymphoma of peripheral nerve: report of four cases. Am J Surg Pathol 24(9): 1257-1265, 2000
53. Roncaroli F, Poppi M, Riccioni L, Frank F: Primary non-Hodgkin's lymphoma of the sciatic nerve followed by localization in the central nervous system: case report and review of the literature. Neurosurgery 40(3): 618-621, 1997 discussion 621-622 (Review)
54. Cantone G, Rath SA, Richter HP: Intraneural metastasis in a peripheral nerve. Acta Neurochir (Wien) 142(6): 719-720, 2000
55. Detterbeck FC: Pancoast (superior sulcus) tumors. Ann Thorac Surg 63(6): 1810-1818, 1997
56. Olsen NK, Pfeiffer P, Mondrup K, Rose C: Radiation-induced brachial plexus neuropathy in breast cancer patients. Acta Oncol 29(7): 885-890, 1990
57. LeQuang C: Postirradiation lesions of the brachial plexus. Results of surgical treatment. Hand Clin. 5(1): 23-32, 1989